Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Minuto

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cellsA Barreca, P G Artini, P Del Monte, et al.
Journal of Endocrinological Investigation|June 19, 2008
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian populationG Aimaretti, M Boschetti, G Corneli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2004
Somatostatin receptor distribution and function in immune systemD Ferone, P M van Hagen, C Semino, et al.
Molecular and Cellular Endocrinology|November 12, 2013
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growthM Ruscica, P Magni, L Steffani, et al.
Journal of Endocrinological Investigation|April 5, 2012
Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogsL E A Wildemberg, L V Neto, D F Costa, et al.
Journal of Endocrinological Investigation|April 9, 2002
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?G Pittoni, G Gallioi, M Zanello, et al.
European Thyroid Journal|November 16, 2016
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational StudyF Cecoli, E M Ceresola, V Altrinetti, et al.
Journal of Endocrinological Investigation|July 19, 2011
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphyD Ferone, R Pivonello, D J Kwekkeboom, et al.
Journal of Endocrinological Investigation|June 23, 2009
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegalyG Lombardi, F Minuto, G Tamburrano, et al.
Journal of Endocrinological Investigation|October 10, 2007
Pegvisomant in acromegaly: why, when, howA Colao, G Arnaldi, P Beck-Peccoz, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|July 1, 1993
In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cellsA Barreca, P G Artini, P Del Monte, et al.
Journal of Endocrinological Investigation|June 19, 2008
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian populationG Aimaretti, M Boschetti, G Corneli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2004
Somatostatin receptor distribution and function in immune systemD Ferone, P M van Hagen, C Semino, et al.
Molecular and Cellular Endocrinology|November 12, 2013
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growthM Ruscica, P Magni, L Steffani, et al.
Journal of Endocrinological Investigation|April 5, 2012
Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogsL E A Wildemberg, L V Neto, D F Costa, et al.
Journal of Endocrinological Investigation|April 9, 2002
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?G Pittoni, G Gallioi, M Zanello, et al.
European Thyroid Journal|November 16, 2016
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational StudyF Cecoli, E M Ceresola, V Altrinetti, et al.
Journal of Endocrinological Investigation|July 19, 2011
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphyD Ferone, R Pivonello, D J Kwekkeboom, et al.
Journal of Endocrinological Investigation|June 23, 2009
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegalyG Lombardi, F Minuto, G Tamburrano, et al.
Journal of Endocrinological Investigation|October 10, 2007
Pegvisomant in acromegaly: why, when, howA Colao, G Arnaldi, P Beck-Peccoz, et al.
Pageof 15